{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:59:39Z","timestamp":1790690379947,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clinthera.2026.08.019","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:07:04Z","timestamp":1790687224000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bridging the Gap Between IND Safety Reporting and Routine Clinical Practice: Operational, Cognitive, and Training Challenges at Investigative Sites"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9957-9785","authenticated-orcid":false,"given":"Emilia","family":"Jones Amaowei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Byrth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2026.08.019_bib0001","unstructured":"U.S. Food and Drug Administration. Inspection Observations. https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/inspection-references\/inspection-observations, 2025. Accessed September 22, 2026."},{"key":"10.1016\/j.clinthera.2026.08.019_bib0002","unstructured":"Agency for Healthcare Research and Quality Patient Safety Network. Electronic health records. https:\/\/psnet.ahrq.gov\/primer\/electronic-health-records. 2019. Accessed September 22, 2026."},{"key":"10.1016\/j.clinthera.2026.08.019_bib0003","unstructured":"U.S. Food and Drug Administration. 21 CFR \u00a7312.64\u2014Investigator reports. Electronic code of federal regulations. eCFR :: 21 CFR 312.64 -- Investigator reports. https:\/\/www.ecfr.gov\/current\/title-21\/chapter-I\/subchapter-D\/part-312\/subpart-D\/section-312.64. 2026. Accessed September 22, 2026."},{"key":"10.1016\/j.clinthera.2026.08.019_bib0004","unstructured":"U.S. Food and Drug Administration. 21 CFR \u00a73.32\u2014IND safety reporting. Electronic code of federal regulations. https:\/\/www.ecfr.gov\/current\/title-21\/chapter-I\/subchapter-D\/part-312\/subpart-B\/section-312.32. 2026. Accessed September 22, 2026."},{"key":"10.1016\/j.clinthera.2026.08.019_bib0007","unstructured":"U.S. Department of Health and Human Services, Office for Human Research Protections. Reviewing and reporting unanticipated problems involving risks to subjects or others and adverse events. https:\/\/www.hhs.gov\/ohrp\/regulations-and-policy\/guidance\/reviewing-unanticipated-problems\/index.html, 2007. Accessed September 22, 2026."},{"key":"10.1016\/j.clinthera.2026.08.019_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2019.105918","article-title":"Improving the quality conduct and efficiency of clinical trials with training: recommendations for preparedness and qualification of investigators and delegates","volume":"89","author":"Bechtel","year":"2020","journal-title":"Contemp Clin Trials"},{"issue":"3","key":"10.1016\/j.clinthera.2026.08.019_bib0009","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1097\/PTS.0000000000000911","article-title":"Challenges and barriers to adverse event reporting in clinical trials: a Children\u2019s Oncology Group Report","volume":"18","author":"Miller","year":"2022","journal-title":"J Patient Saf"},{"key":"10.1016\/j.clinthera.2026.08.019_bib0010","unstructured":"Agency for Healthcare Research and Quality Patient Safety Network. Handoffs. https:\/\/psnet.ahrq.gov\/primer\/handoffs 2019. Accessed September 22, 2026."},{"key":"10.1016\/j.clinthera.2026.08.019_sbref0011","series-title":"Medication Safety in Transitions of Care. WHO\/UHC\/SDS\/2019.9","year":"2019"},{"key":"10.1016\/j.clinthera.2026.08.019_bib0012","unstructured":"International Council for Harmonisation. ICH E6(R3) good clinical practice. 2025. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/e6r3-good-clinical-practice-gcp Accessed September 22, 2026."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826003358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826003358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:07:07Z","timestamp":1790687227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291826003358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":10,"alternative-id":["S0149291826003358"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.08.019","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging the Gap Between IND Safety Reporting and Routine Clinical Practice: Operational, Cognitive, and Training Challenges at Investigative Sites","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}